BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 1826699)

  • 21. Plasma cells tumors decrease CD23 mRNA expression in vivo in murine splenic B cells.
    Ruzek MC; Mathur A
    Eur J Immunol; 1995 Aug; 25(8):2228-33. PubMed ID: 7664786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo activation of murine gamma/delta T cells induces the expression of IgA, IgM, and IgG Fc receptors.
    Sandor M; Houlden B; Bluestone J; Hedrick SM; Weinstock J; Lynch RG
    J Immunol; 1992 Apr; 148(8):2363-9. PubMed ID: 1532812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. I. A new class of molecules, termed IgE-induced regulants (EIR), which modulate FcR epsilon expression by lymphocytes.
    Marcelletti JF; Katz DH
    J Immunol; 1984 Dec; 133(6):2821-8. PubMed ID: 6238084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
    Santos-Argumedo L; Gordon J; Heath AW; Howard M
    Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
    Galizzi JP; Cabrillat H; Rousset F; Ménétrier C; de Vries JE; Banchereau J
    J Immunol; 1988 Sep; 141(6):1982-8. PubMed ID: 2844892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of murine B cell Fc gamma RII expression by CD4+ T helper subsets.
    Snapper CM; Hooley JJ; Atasoy U; Finkelman FD; Paul WE
    J Immunol; 1989 Oct; 143(7):2133-41. PubMed ID: 2528589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cell activator. Effects on B cell expression of CD23, proliferation, and antibody secretion.
    Marcelletti JF; Matsushita S; Katz DH
    J Immunol; 1992 Jun; 148(12):3857-63. PubMed ID: 1318334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fc gamma RII expression in resting and activated B lymphocytes.
    Amigorena S; Bonnerot C; Choquet D; Fridman WH; Teillaud JL
    Eur J Immunol; 1989 Aug; 19(8):1379-85. PubMed ID: 2550246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of transforming growth factor (TGF)-beta 1 on IgA isotype expression. TGF-beta 1 induces a small increase in sIgA+ B cells regardless of the method of B cell activation.
    Ehrhardt RO; Strober W; Harriman GR
    J Immunol; 1992 Jun; 148(12):3830-6. PubMed ID: 1602131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23).
    Delespesse G; Sarfati M; Peleman R
    J Immunol; 1989 Jan; 142(1):134-8. PubMed ID: 2521231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B lymphocytes of mice display an aberrant activation phenotype and are cell cycle arrested in G0/G1A during acute infection with Trypanosoma brucei.
    Sacco RE; Hagen M; Donelson JE; Lynch RG
    J Immunol; 1994 Aug; 153(4):1714-23. PubMed ID: 7519210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
    Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
    J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
    Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional implication for the topographical relationship between MHC class II and the low-affinity IgE receptor: occupancy of CD23 prevents B lymphocytes from stimulating allogeneic mixed lymphocyte responses.
    Flores-Romo L; Johnson GD; Ghaderi AA; Stanworth DR; Veronesi A; Gordon J
    Eur J Immunol; 1990 Nov; 20(11):2465-9. PubMed ID: 2147649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. III. Suppressive factor of allergy (SFA) is produced during the in vitro FcR epsilon expression cascade and displays corollary physiologic activity in vivo.
    Marcelletti JF; Katz DH
    J Immunol; 1984 Dec; 133(6):2837-44. PubMed ID: 6238086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.
    Kehrl JH; Thevenin C; Rieckmann P; Fauci AS
    J Immunol; 1991 Jun; 146(11):4016-23. PubMed ID: 1903417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of Fc gamma receptors on murine spleen cell populations by using dual parameter flow cytometry.
    Titus JA; Finkelman FD; Stephany DA; Jones JF; Segal DM
    J Immunol; 1984 Aug; 133(2):556-61. PubMed ID: 6234350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential induction of class II gene expression in murine pre-B-cell lines by B-cell stimulatory factor-1 and by antibodies to B-cell surface antigens.
    Polla BS; Ohara J; Paul WE; Nabavi N; Myer A; Liou HC; Shen FW; Gillis S; Bonventre JV; Glimcher LH
    J Mol Cell Immunol; 1988; 3(6):363-73. PubMed ID: 3151065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of the interleukin-2 receptor gamma subunit in interleukin-4-dependent activation of mouse hematopoietic cells and splenic B cells.
    Watanabe S; Kondo M; Takatsu K; Sugamura K; Arai K
    Eur J Immunol; 1995 Jan; 25(1):126-31. PubMed ID: 7843221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.